Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 820

1.

Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease.

Engler H, Doenlen R, Riether C, Engler A, Niemi MB, Besedovsky HO, del Rey A, Pacheco-López G, Feldon J, Schedlowski M.

Brain Behav Immun. 2009 May;23(4):518-26. doi: 10.1016/j.bbi.2009.01.018. Epub 2009 Feb 7.

PMID:
19486644
3.

Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.

Ogura T, Ogata M, Akita H, Jitsuki S, Akiba L, Noda K, Hoka S, Saji M.

Neurosci Res. 2005 Mar;51(3):299-308. Epub 2005 Jan 8.

PMID:
15710494
4.
5.

Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model.

Park HJ, Lim S, Joo WS, Yin CS, Lee HS, Lee HJ, Seo JC, Leem K, Son YS, Kim YJ, Kim CJ, Kim YS, Chung JH.

Exp Neurol. 2003 Mar;180(1):93-8.

PMID:
12668152
6.

The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.

Datla KP, Bennett RD, Zbarsky V, Ke B, Liang YF, Higa T, Bahorun T, Aruoma OI, Dexter DT.

J Pharm Pharmacol. 2004 May;56(5):649-54.

PMID:
15142343
7.

Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.

Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF.

Brain Res Mol Brain Res. 2005 Mar 24;134(1):155-61.

PMID:
15790539
8.

NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.

Bustos G, Abarca J, Bustos V, Riquelme E, Noriega V, Moya C, Campusano J.

J Neurosci Res. 2009 Aug 1;87(10):2308-18. doi: 10.1002/jnr.22063.

PMID:
19326433
9.

Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats.

Henze C, Earl C, Sautter J, Schmidt N, Themann C, Hartmann A, Oertel WH.

Brain Res. 2005 Aug 2;1052(1):97-104.

PMID:
16005444
10.

Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease.

Tadaiesky MT, Dombrowski PA, Figueiredo CP, Cargnin-Ferreira E, Da Cunha C, Takahashi RN.

Neuroscience. 2008 Oct 28;156(4):830-40. doi: 10.1016/j.neuroscience.2008.08.035. Epub 2008 Sep 9.

PMID:
18817851
11.

Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.

Neurobiol Dis. 2006 May;22(2):421-34. Epub 2006 Feb 9.

PMID:
16480889
12.

The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system.

Herrera AJ, Castaño A, Venero JL, Cano J, Machado A.

Neurobiol Dis. 2000 Aug;7(4):429-47.

PMID:
10964613
13.

Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease.

Harvey BK, Mark A, Chou J, Chen GJ, Hoffer BJ, Wang Y.

Brain Res. 2004 Oct 1;1022(1-2):88-95.

PMID:
15353217
14.

Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease.

Depino AM, Earl C, Kaczmarczyk E, Ferrari C, Besedovsky H, del Rey A, Pitossi FJ, Oertel WH.

Eur J Neurosci. 2003 Nov;18(10):2731-42.

PMID:
14656322
16.

Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies.

Xu L, Sheng J, Tang Z, Wu X, Yu Y, Guo H, Shen Y, Zhou C, Paraoan L, Zhou J.

Neurobiol Dis. 2005 Feb;18(1):152-65.

PMID:
15649706
17.

Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats.

Kim YK, Lim HH, Song YK, Lee HH, Lim S, Han SM, Kim CJ.

Neurosci Lett. 2005 Aug 12-19;384(1-2):133-8.

PMID:
15893426
18.

Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.

Yuan H, Sarre S, Ebinger G, Michotte Y.

J Neurosci Methods. 2005 May 15;144(1):35-45. Epub 2004 Dec 8.

PMID:
15848237
19.

Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease.

Camp DM, Loeffler DA, Farrah DM, Borneman JN, LeWitt PA.

J Neuroinflammation. 2009 Jun 5;6:17. doi: 10.1186/1742-2094-6-17.

20.

Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease.

Fu Y, Ito M, Fujita Y, Ito M, Ichihara M, Masuda A, Suzuki Y, Maesawa S, Kajita Y, Hirayama M, Ohsawa I, Ohta S, Ohno K.

Neurosci Lett. 2009 Apr 3;453(2):81-5. doi: 10.1016/j.neulet.2009.02.016. Epub 2009 Feb 12.

PMID:
19356598

Supplemental Content

Support Center